[{"data":1,"prerenderedAt":30},["ShallowReactive",2],{"fbq-id":3,"news-en-juris-bundulis-has-been-appointed-chairman-of-the-board-of-as-ab-city":4},"229099849130020",{"data":5,"error":23,"breadcrumbs":24},{"detailImage":6,"detailImageAlt":10,"title":11,"url":12,"seoTitle":11,"seoDescription":10,"seoKeywords":10,"seoRobots":13,"date":14,"body":15,"i18n":20},{"url":7,"width":8,"height":9},"\u002Fuploads\u002Flarge_079_izvele_portrets_juris_bundulis_foto_kristaps_hercs_1_1723f7d08f.jpg",900,601,"","Juris Bundulis has been appointed chairman of the board of AS “AB City”","juris-bundulis-has-been-appointed-chairman-of-the-board-of-as-ab-city","index, follow","30.06.2026.",[16],{"__component":17,"id":18,"text":19},"article-body.text",818,"**As of June 29, 2026, Juris Bundulis has been appointed chairman of the board of AS “AB City”, a Latvian healthcare and pharmaceutical group. In his new role, he will lead the group's further development across the Baltics and Europe, strengthening its competitiveness in the healthcare and pharmaceutical sectors.**\n\n> \"We are proud that “AB City” is one of Latvia's largest local private capital companies and employers, which has grown over more than 35 years in Latvia into an international healthcare and pharmaceutical group. The group`s companies continue to make targeted investments in the development and accessibility of healthcare in Latvia, while also expanding their presence in international markets. We are confident that Juris Bundulis' extensive experience in the healthcare and pharmaceutical sectors, combined with his strategic vision, will make a significant contribution to the group's continued growth and strengthen our competitiveness across the Baltics and the European Union,\" **says Andrejs Leibovičs, chairman of the supervisory board of AS “AB City”.**\n\n“AB City” is a Latvian local private capital company with a primary focus on the Baltic region while continuing to expand across the European Union (EU) and other international markets. Pharmaceutical products developed and manufactured by the group's companies in Latvia are exported to numerous countries worldwide. The group also continues to expand its healthcare services export, pharmaceutical research and development (R&D), and contract manufacturing services for international partners.\n\n> ““AB City”” is a unique Latvian healthcare companies’ group with a strong foundation of local private capital and ambitions on an international scale. “AB City's” development strategy is focused on strengthening the group's position across the Baltics and the European Union, enhancing its operational efficiency and competitiveness, while ensuring sustainable growth. The group's companies are already making a significant contribution to healthcare and the availability of medicines in Latvia, but I see even greater potential ahead. Across Europe, there is an increasing focus on the resilience of healthcare systems and on strengthening and localising the production of critical medicines. Latvian companies have every opportunity to become an important part of this ecosystem. Our task will be to continue advancing innovation, export capacity and international cooperation, while strengthening Latvia's role as a trusted partner in the pharmaceutical and healthcare sectors in Latvia and across Europe,\" **says Juris Bundulis, chairman of the board AS “AB City”.**\n\nJuris Bundulis has more than 30 years of experience in Latvia's pharmaceutical and healthcare sectors. During his career, he has worked at the Latvian Institute of Organic Synthesis and AS “Grindeks”, as well as held senior positions at the Ministry of Health and the Ministry of Welfare of Latvia. Until January 2026, he served as Chairman of the Management Board of AS “Olpha” and continues to serve on the company's Supervisory Board. Juris Bundulis is also Chair of the Health Committee of the Latvian Chamber of Commerce and Industry. He holds an honorary doctorate in biology (Dr. h.c. biol.) awarded by the Latvian Academy of Sciences.\n\n“AB City” group involves pharmaceutical, healthcare, laboratory, medical services and other health sector-related companies operating across the Baltics. The “AB City” group is one of Latvia's largest local private capital employers, with more than 5,700 employees. In 2024, the group's combined turnover exceeded EUR 610 million, and its companies contributed EUR 85 million in taxes to the Latvian state budget. Between 2022 and the end of 2024, the “AB City” group`s companies invested more than EUR 129 million in development projects.",{"en":21,"lv":22},"\u002Fen\u002Fnews\u002Fjuris-bundulis-has-been-appointed-chairman-of-the-board-of-as-ab-city","\u002Fjaunumi\u002Fas-ab-city-valdes-priekssedetaja-amata-iecelts-juris-bundulis",[],{"title":11,"list":25},[26,29],{"text":27,"url":28},"News","news",{"text":11},1782887746832]